| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.009 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |